Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
12.60
-0.26 (-2.02%)
Nov 20, 2024, 4:00 PM EST - Market closed

Mineralys Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for MLYS stock have an average target of 30, which predicts an increase of 138.10% from the current stock price of 12.60.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $30 $30 $30 $30
Change +138.10% +138.10% +138.10% +138.10%

Analyst Ratings

The average analyst rating for MLYS stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 122222
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 122222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$30
Strong Buy Reiterates $30 +138.10% Nov 12, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$30
Strong Buy Reiterates $30 +138.10% Oct 31, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$30
Strong Buy Reiterates $30 +138.10% Aug 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$30
Strong Buy Initiates $30 +138.10% Jul 10, 2024
Goldman Sachs
Goldman Sachs
Strong Buy
Initiates
$30
Strong Buy Initiates $30 +138.10% Apr 2, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.26
from -1.99
EPS Next Year
-3.47
from -3.26
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
------11.78M79.63M
Revenue Growth
-------575.89%
EPS
-0.74-3.89-5.77-1.99-3.26-3.47-3.44-4.02
EPS Growth
--------
Forward PE
--------
No. Analysts ----9875
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High n/a n/a 60.6M
Avg n/a n/a 11.8M
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 20242025202620272028
High -2.72 -3.18 -2.66
Avg -3.26 -3.47 -3.44
Low -3.41 -3.59 -3.89

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.